甲状腺结节三维超声及超声引导下甲状腺穿刺的临床研究
|
摘要
第一部分甲状腺结节三维灰阶超声及三维能量多普勒超声血管成像与常规超声的对比研究
目的
观察甲状腺结节的三维灰阶超声(3D)和三维能量多普勒超声血管成像(3D-PDA)特征,与常规超声进行比较,探讨三维灰阶超声及三维能量多普勒超声血管成像对甲状腺良恶性结节的鉴别诊断价值。
资料和方法
2008年3月～2009年4月94例行甲状腺手术患者共103个甲状腺结节进行三维灰阶超声及三维能量多普勒超声血管成像研究。
采用三维灰阶多平面成像方式对甲状腺结节进行三维重建。观察甲状腺结节与被膜关系、形态、边界、晕、内部回声、实性部分回声水平、均一性、钙化形态。
采用三维能量多普勒超声成像对甲状腺结节及周边血流进行三维重建。分析血流分布、血管流数量、血管走行是否规则、空间分布是否对称、结节内是否存在局部血流丰富、结节周边实质是否存在局部血流丰富。
分析不同病理类型甲状腺结节的三维灰阶超声及三维能量多普勒超声血管成像特征,比较良恶性结节之间的差异,比较三维灰阶超声成像及三维能量多普勒超声血管成像与常规超声诊断敏感性、特异性、阳性预测值、阴性预测值和准确率。
结果
1.进行三维超声检查的103个甲状腺结节,良性50个(48.5%),恶性53个(51.5%)。甲状腺恶性结节病理构成:乳头状癌48个(90.5%),滤泡癌1个(1.9%),髓样癌3个(5.7%),淋巴瘤1个(1.9%)。恶性结节平均大小为2.13±1.07cm(0.66cm-5.14cm),73.6%的肿瘤为Ⅰ期。良性结节病理构成:结节性甲状腺肿40个(80.0%),腺瘤8个(16.0%),桥本甲状腺炎1个(2.0%),纤维性甲状腺炎(2.0)。良性结节平均大小2.39±0.96 cm(0.78cm-5.32cm)。
2.三维灰阶超声成像声像图特征:甲状腺良性病灶形态规则(88.0%)、边界清晰(84.0%)、有完整规则晕(54.0%)、囊实性(52.0%)、等回声(66.0%)、回声不均(72.0%)、无钙化(64.0%)。甲状腺恶性病灶形态不规则(90.6%)、边界模糊(47.2%)、无晕(62.3%)、实性(94.3%)、低回声(90.6%)、回声不均(90.6%)、有微小钙化(79.2%)。
3.三维能量多普勒超声血管成像声像图特征:良性病灶血管走行规则(96.0%)、空间分布对称(88.0%)、结节内(96.0%)及结节周边实质(94.0%)不存在局部血流丰富;恶性病灶血管走行不规则(66.2%),空间分布不对称(56.6%),结节内(54.7%)及结节周边实质(60.4%)存在局部血流丰富。
4.三维灰阶超声诊断效率(敏感性88.7%,特异性90.0%,阳性预测值90.4%,阴性预测值88.2%,准确率89.3%)高于二维灰阶超声(敏感性86.8%,特异性86.0%,阳性预测值86.8%,阴性预测值86.0%,准确率86.4%。);三维能量多普勒超声诊断效率(敏感性83.0%,特异性94.0%,阳性预测值93.6%,阴性预测值83.9%,准确率90.3%)高于彩色多普勒血流显像(敏感性75.5%,特异性92.0%,阳性预测值90.9%,阴性预测值78.0%,准确率83.5%)。
结论
甲状腺良恶性结节的三维灰阶超声成像声像图特征及三维能量多普勒超声血管成像声像图特征具有显著差异。三维灰阶超声的诊断敏感性、特异性高于二维灰阶超声。三维能量多普勒超声的诊断敏感性、特异性高于彩色多普勒超声。三维超声成像在灰阶成像和血管成像两方面为甲状腺结节的诊断和鉴别诊断提供了更多的信息,具有重要的临床应用价值。
第二部分超声引导下细针吸取细胞学检查及组织活检对甲状腺结节的诊断价值
目的
1.评估超声引导下细针吸取细胞学检查(US-FNA)及超声引导下粗针活检(US-CNB)对甲状腺结节的诊断价值。
2.初步探讨薄层液基细胞学涂片在甲状腺穿刺中的应用价值。
资料和方法
2004年11月至2008年10月168例患者的175个甲状腺结节进行超声引导下细针吸取细胞学检查。其中男28例,女140例。男女之比为1:5.0。年龄4-75岁,平均43.6岁。其中63例获得手术病理,其余病例全部进行临床随访,随访时间7个月-4年4个月。53例患者的53个甲状腺结节进行超声引导下粗针活检,其中男6例,女47例。男女之比1:7.8。年龄13-74岁,平均44.0岁。其中24例获得手术病理,其余病例全部进行临床随访,随访时间7个月-4年4个月。57个结节同时进行了薄层液基细胞学涂片,随访时间9月-1年2个月。
将穿刺细胞学及组织学的诊断资料与手术病理及临床随访结果进行对照分析。细胞学及组织学诊断结果分为四类:良性、恶性、可疑恶性及涂片不满意。分析薄层液基细胞学涂片的细胞学特征。
结果
1.US-FNA的175个甲状腺结节经病理及临床随访证实恶性结节39个,良性结节136个。细胞学诊断良性71%(124/175),恶性14%(24/175),可疑恶性8%(14/175),涂片不满意7%(13/175)。US-FNA诊断敏感性81.1%,特异性93.6%,准确性90.7%,阳性预测值78.9%,阴性预测值94.4%。恶性结节细胞学涂片诊断率66.7%,凝血组织块诊断率88.9%。假阴性7例,假阳性8例。3例发生穿刺后出血。
2.US-FNA对实性甲状腺癌的诊断敏感性82.9%,特异性91.7%准确性88.8%,阳性预测值82.9%,阴性预测值91.7%。对囊实性甲状腺癌的诊断敏感性50.0%,特异性96.3%准确性94.6%,阳性预测值33.3%,阴性预测值98.1%。
3.US-FNA对≤1cm实性甲状腺结节的诊断敏感性75.0%,特异性96.7%准确性94.1%,阳性预测值75.0%,阴性预测值96.7%。对＞1cm实性结节的诊断敏感性83.9%,特异性88.1%准确性86.3%,阳性预测值83.9%,阴性预测值88.1%。
4.US-CNB的53个甲状腺结节经病理及临床随访证实恶性结节22个,良性结节31个。组织活检诊断良性66%(35/53),恶性28%(15/53),可疑恶性4%(2/53),涂片不满意2%(1/53)。US-CNB对甲状腺结节诊断敏感性81.0%,特异性100%准确性92.5%,阳性预测值100%,阴性预测值88.6%。假阴性4例,无假阳性。2例发生穿刺后出血。
5.薄层液基细胞学涂片的不满意率8.8%,相对于常规涂片,其主要特征为背景血细胞明显减少、细胞量较多、集中,利于阅片。胶质量少或浓集、核较深染、细胞皱缩更常见、常见细胞质碎片及裸核。其诊断效率和FNA相仿。
结论
1.甲状腺US-FNA细胞学检查及US-CNB并发症少,诊断准确性好,是诊断甲状腺结节的可靠方法。
2.甲状腺US-FNA与US-CNB相比,CNB诊断的特异性、阳性预测值略高,FNA诊断的阴性预测值略高,其他相仿。FNA操作更为简便,安全性更高,完全能够满足临床需要。
3.FNA对实性结节诊断的敏感性高,对囊实性结节诊断敏感性低。在临床应用中应根据实际情况判断穿刺结果。
4.细胞学涂片及凝血组织块联合应用可以提高恶性结节的检出率。
5.薄层液基细胞学涂片在甲状腺结节FNA中有较好的应用价值,其涂片细胞学特征与常规涂片有一定差异。
Part I The Study of Thyroid Nodules with 3-Dimensional Ultrasound and 3-Dimensional Power Doppler Ultrasound
Purpose
To observe the sonographic features of thyroid nodules with 3-Dimensional Ultrasound and 3-Dimensional Power Doppler Ultrasound and compare with conventional ultrasound. To assess the value of 3-Dimensional Ultrasound and 3-Dimensional Power Doppler Ultrasound in differentiating benign and malignant thyroid nodules.
Material and methods
From Mar 2008 to Apr 2009, ninety-four patients scheduled for surgical removal of the nodules were evaluated with 3D ultrasound and 3D-Power Doppler ultrasound. Of the 103 lesions, 50 lesions were benign, 53 were malignant.
In 3D ultrasound, with the mltiplanar reformation, the sonographic features of the thyroid nodules were observed for the location with the capsule, shape, margin, halo, internal texture, echogenicity, homogenicity and calcification.
In 3D power Doppler ultrasound, with the color mode, the location, quantity, formation, spatial distribution of the thyroid nodules vascular, as well as whether there was the presence of local abundant vascular in the nodules or in the perinodular area of the nodules were observed.
To analyse the features of thyroid nodules in the 3D ultrasound and 3D power Doppler ultrasound with respect to the histological results. In additional, the sensitive, specificity, PPV (positive predictive value), NPV(negative predictive value), accuracy of the 3D ultrasound and 3D power Doppler ultrasound were calculated and compared with conventional ultrasound.
Results
1. Of all the 103 lesions underwent 3D ultrasound examination, 50 (48.5%) were benign and 53 (51.5%) were malignant. The malignant lesions included 48 (90.5%) papillary thyroid carcinoma (PTC), 1 (1.9%) follicular carcinoma, 3 (5.7%) medullary thyroid carcinoma (MTC), 1 (1.9%) lymphoma. The mean size of the malignant lesions was 2.13±1.07cm (0.66cm-5.14cm) , in 73.6% of patients they were stage I. The benign lesions included 40 (80.0%) goiter, 8 (16.0%) adenoma, 1 (2.0%) Hashimoto's disease, 1 (2.0%) fibrous thyroiditis. The mean size of the benign lesions was 2.39±0.96 cm (0.78cm-5.32cm) .
2. The sonographic features of 3D ultrasound of benign lesions included regular contours (88.0%), well-defined margin (84.0%), complete and regular halo (54.0%), solid with cystic components (52.0%), iso-echogenicity (66.0%), ununiform echogenicity(72.0%) ,without calcification (64.0%) . The sonographic features of 3D ultrasound of malignant lesions included irregular contours (90.6%), ill-defined margin (47.2%), no halo (62.3%), solid (94.3%), ununiform echogenicity (90.6%), hypo-echogenicity(90.6%), microcalcification (79.2%) .
3. The sonographic features of 3D power Doppler ultrasound of benign lesions included regular (96.0%), symmetric (88.0%) vascular, the absence of the local abundant vascular in the nodules (96.0%) and in the perinodular area of the nodules(94.0%) . The sonographic features of 3D power Doppler ultrasound of malignant lesions included irregular (66.2%), asymmetric vascular (56.6%), the presence of the local abundant vascular in the nodules (54.7%) and in the perinodular area of the nodules (60.4%) .
4. The sensitivity, specificity, PPV, NPV, ACC of 3D ultrasound were 88.7%, 90.0%, 90.4%, 88.2%, 89.3%, which were superior to 2D ultrasound with the sensitivity/ specificity/PPV/NPV/ACC of 86.8%/86.0%/86.8%/86.0%/86.4%. The sensitivity, specificity, PPV, NPV, ACC of 3D power Doppler ultrasound was 83.0%, 94.0%, 93.6%, 83.9%, 90.3%, which were superior to CDFI with the sensitivity/specificity/ PPV/NPV/ACC of 75.5%/92.0%/90.9%/78.0%/83.5%.
Conclusions
There is significant difference in sonographic features between the benign and malignant thyroid lesions of 3D ultrasound and 3D power Doppler ultrasound. The sensitivity and specificity of 3D is superior to 2D ultrasound. The sensitivity and specificity of 3D power Doppler ultrasound is superior to CDFI. 3D ultrasound and 3D power Doppler ultrasound provide more information of the thyroid nodules and are of great value in diagnosing and differentiating thyroid nodules.
Part II Ultrasound-guided fine-needle aspiration and core-needle biopsy in the diagnosis of thyroid
Objective
1. Evaluate the efficacy of ultrasound-guided fine-needle aspiration (US-FNA) and core needle biopsy (US-CNB) of thyroid nodules.
2. To assess the value of Thin-Layer preparation (TP) in diagnosing thyroid disease and compared with conventional preparation (CP) .
Material and methods
175 thyroid FNA were prospectively performed on 168 patients ranging from 4 to 75 years of age.
53 thyroid CB were prospectively performed on 53 patients ranging from 13 to 74 years of age.
57 thyroid FNA were performed with TP preparation simultaneously.
The cytology and histological diagnoses were categorized into four groups: benign, malignant, suspicious, and unsatisfactory. Analysis the character of cytology of TP.
Results
1. There were 39 malignant nodules and 136 benign nodules proved by histological diagnoses and clinical follow-up. One hundred and twenty four (71%) of the aspirates were diagnosed as "benign", twenty four (14%) were diagnosed as "malignant", fourteen (8%) were diagnosed as "suspicious for malignant", thirteen (7%) were read as unsatisfactory for interpretation. Sensitivity of thyroid FNA in diagnosing thyroid malignancy relative to final histological diagnoses and clinical follow-up was 81.1%, specificity was 93.6%, accuracy was 90.7%, PPV was 78.9%, NPV was 94.4%. 7 cases was false negative. 8 cases was false positive. Bleeding was observed in 3 nodules(1.7%).
2. Sensitivity/specificity/accuracy/PPV/NPV of US-FNA in diagnosing solid thyroid nodule was 82.9%, 91.7%, 88.8%, 82.9%, 91.7%. Sensitivity/ specificity/ accuracy/PPV/NPV of US-FNA in diagnosing cyst-solid thyroid nodule was 50.0%, 96.3%, 94.6%, 33.3%, 98.1%.
3. Sensitivity/specificity/accuracy/PPV/NPV of US-FNA in diagnosing solid thyroid nodule with a diameter of 1cm or smaller was 75.0%, 96.7%, 94.1%, 75.0%, 96.7%. Sensitivity/specificity/accuracy/PPV/NPV of US-FNA in diagnosing solid thyroid nodule with a diameter larger than 1cm was 83.9%, 88.1%, 86.3%, 83.9%, 88.1%.
4. There were 22 malignant nodules and 31 benign nodules proved by histological diagnoses and clinical follow-up. Thirty five (66%) of the biopsies aspirates were diagnosed as "benign", fifteen (28%) were diagnosed as "malignant", two (4%) were diagnosed as "suspicious for malignant", one (2%) was read as unsatisfactory for interpretation. Sensitivity of thyroid FNA in diagnosing thyroid malignancy relative to final histological diagnoses and clinical follow-up was 81.0%, specificity was 100%, accuracy was 92.5%, PPV was 100%, NPV was 88.6%. Bleeding was observed in 2 nodules (3.8%).
5. The inadequate rate of TP is 8.8%, compared with conventional smears, the cytology character of TP included markedly decreased background blood cells, decreased or dense colloid, more cell shrinkage, densely stained nuclear, disruption of the cytoplasm and numerous naked nuclei.
Conclusions
1. US-FNA and US-CNB were accurate and reliable methods to diagnose thyroid nodules.
2. The specificity and PPV of CNB is a little higher than FNA. The sensitivity of FNA is a little higher than CNB. FNA is more convenient and safe, with satisfactory efficacy.
3. The sensitivity of FNA is high in diagnosing solid thyroid nodules but relatively low in diagnosing cyst-solid thyroid nodules. We should interpret the results in consideration with different clinical conditions.
4. The combination of cytological smears and histological cell block helps to detect malignant thyroid nodules.
5. Thin-layer preparation is of great value in diagnosing thyroid disease, the character of the cytology is different from conventional preparation.
目的
观察甲状腺结节的三维灰阶超声(3D)和三维能量多普勒超声血管成像(3D-PDA)特征,与常规超声进行比较,探讨三维灰阶超声及三维能量多普勒超声血管成像对甲状腺良恶性结节的鉴别诊断价值。
资料和方法
2008年3月～2009年4月94例行甲状腺手术患者共103个甲状腺结节进行三维灰阶超声及三维能量多普勒超声血管成像研究。
采用三维灰阶多平面成像方式对甲状腺结节进行三维重建。观察甲状腺结节与被膜关系、形态、边界、晕、内部回声、实性部分回声水平、均一性、钙化形态。
采用三维能量多普勒超声成像对甲状腺结节及周边血流进行三维重建。分析血流分布、血管流数量、血管走行是否规则、空间分布是否对称、结节内是否存在局部血流丰富、结节周边实质是否存在局部血流丰富。
分析不同病理类型甲状腺结节的三维灰阶超声及三维能量多普勒超声血管成像特征,比较良恶性结节之间的差异,比较三维灰阶超声成像及三维能量多普勒超声血管成像与常规超声诊断敏感性、特异性、阳性预测值、阴性预测值和准确率。
结果
1.进行三维超声检查的103个甲状腺结节,良性50个(48.5%),恶性53个(51.5%)。甲状腺恶性结节病理构成:乳头状癌48个(90.5%),滤泡癌1个(1.9%),髓样癌3个(5.7%),淋巴瘤1个(1.9%)。恶性结节平均大小为2.13±1.07cm(0.66cm-5.14cm),73.6%的肿瘤为Ⅰ期。良性结节病理构成:结节性甲状腺肿40个(80.0%),腺瘤8个(16.0%),桥本甲状腺炎1个(2.0%),纤维性甲状腺炎(2.0)。良性结节平均大小2.39±0.96 cm(0.78cm-5.32cm)。
2.三维灰阶超声成像声像图特征:甲状腺良性病灶形态规则(88.0%)、边界清晰(84.0%)、有完整规则晕(54.0%)、囊实性(52.0%)、等回声(66.0%)、回声不均(72.0%)、无钙化(64.0%)。甲状腺恶性病灶形态不规则(90.6%)、边界模糊(47.2%)、无晕(62.3%)、实性(94.3%)、低回声(90.6%)、回声不均(90.6%)、有微小钙化(79.2%)。
3.三维能量多普勒超声血管成像声像图特征:良性病灶血管走行规则(96.0%)、空间分布对称(88.0%)、结节内(96.0%)及结节周边实质(94.0%)不存在局部血流丰富;恶性病灶血管走行不规则(66.2%),空间分布不对称(56.6%),结节内(54.7%)及结节周边实质(60.4%)存在局部血流丰富。
4.三维灰阶超声诊断效率(敏感性88.7%,特异性90.0%,阳性预测值90.4%,阴性预测值88.2%,准确率89.3%)高于二维灰阶超声(敏感性86.8%,特异性86.0%,阳性预测值86.8%,阴性预测值86.0%,准确率86.4%。);三维能量多普勒超声诊断效率(敏感性83.0%,特异性94.0%,阳性预测值93.6%,阴性预测值83.9%,准确率90.3%)高于彩色多普勒血流显像(敏感性75.5%,特异性92.0%,阳性预测值90.9%,阴性预测值78.0%,准确率83.5%)。
结论
甲状腺良恶性结节的三维灰阶超声成像声像图特征及三维能量多普勒超声血管成像声像图特征具有显著差异。三维灰阶超声的诊断敏感性、特异性高于二维灰阶超声。三维能量多普勒超声的诊断敏感性、特异性高于彩色多普勒超声。三维超声成像在灰阶成像和血管成像两方面为甲状腺结节的诊断和鉴别诊断提供了更多的信息,具有重要的临床应用价值。
第二部分超声引导下细针吸取细胞学检查及组织活检对甲状腺结节的诊断价值
目的
1.评估超声引导下细针吸取细胞学检查(US-FNA)及超声引导下粗针活检(US-CNB)对甲状腺结节的诊断价值。
2.初步探讨薄层液基细胞学涂片在甲状腺穿刺中的应用价值。
资料和方法
2004年11月至2008年10月168例患者的175个甲状腺结节进行超声引导下细针吸取细胞学检查。其中男28例,女140例。男女之比为1:5.0。年龄4-75岁,平均43.6岁。其中63例获得手术病理,其余病例全部进行临床随访,随访时间7个月-4年4个月。53例患者的53个甲状腺结节进行超声引导下粗针活检,其中男6例,女47例。男女之比1:7.8。年龄13-74岁,平均44.0岁。其中24例获得手术病理,其余病例全部进行临床随访,随访时间7个月-4年4个月。57个结节同时进行了薄层液基细胞学涂片,随访时间9月-1年2个月。
将穿刺细胞学及组织学的诊断资料与手术病理及临床随访结果进行对照分析。细胞学及组织学诊断结果分为四类:良性、恶性、可疑恶性及涂片不满意。分析薄层液基细胞学涂片的细胞学特征。
结果
1.US-FNA的175个甲状腺结节经病理及临床随访证实恶性结节39个,良性结节136个。细胞学诊断良性71%(124/175),恶性14%(24/175),可疑恶性8%(14/175),涂片不满意7%(13/175)。US-FNA诊断敏感性81.1%,特异性93.6%,准确性90.7%,阳性预测值78.9%,阴性预测值94.4%。恶性结节细胞学涂片诊断率66.7%,凝血组织块诊断率88.9%。假阴性7例,假阳性8例。3例发生穿刺后出血。
2.US-FNA对实性甲状腺癌的诊断敏感性82.9%,特异性91.7%准确性88.8%,阳性预测值82.9%,阴性预测值91.7%。对囊实性甲状腺癌的诊断敏感性50.0%,特异性96.3%准确性94.6%,阳性预测值33.3%,阴性预测值98.1%。
3.US-FNA对≤1cm实性甲状腺结节的诊断敏感性75.0%,特异性96.7%准确性94.1%,阳性预测值75.0%,阴性预测值96.7%。对＞1cm实性结节的诊断敏感性83.9%,特异性88.1%准确性86.3%,阳性预测值83.9%,阴性预测值88.1%。
4.US-CNB的53个甲状腺结节经病理及临床随访证实恶性结节22个,良性结节31个。组织活检诊断良性66%(35/53),恶性28%(15/53),可疑恶性4%(2/53),涂片不满意2%(1/53)。US-CNB对甲状腺结节诊断敏感性81.0%,特异性100%准确性92.5%,阳性预测值100%,阴性预测值88.6%。假阴性4例,无假阳性。2例发生穿刺后出血。
5.薄层液基细胞学涂片的不满意率8.8%,相对于常规涂片,其主要特征为背景血细胞明显减少、细胞量较多、集中,利于阅片。胶质量少或浓集、核较深染、细胞皱缩更常见、常见细胞质碎片及裸核。其诊断效率和FNA相仿。
结论
1.甲状腺US-FNA细胞学检查及US-CNB并发症少,诊断准确性好,是诊断甲状腺结节的可靠方法。
2.甲状腺US-FNA与US-CNB相比,CNB诊断的特异性、阳性预测值略高,FNA诊断的阴性预测值略高,其他相仿。FNA操作更为简便,安全性更高,完全能够满足临床需要。
3.FNA对实性结节诊断的敏感性高,对囊实性结节诊断敏感性低。在临床应用中应根据实际情况判断穿刺结果。
4.细胞学涂片及凝血组织块联合应用可以提高恶性结节的检出率。
5.薄层液基细胞学涂片在甲状腺结节FNA中有较好的应用价值,其涂片细胞学特征与常规涂片有一定差异。
Part I The Study of Thyroid Nodules with 3-Dimensional Ultrasound and 3-Dimensional Power Doppler Ultrasound
Purpose
To observe the sonographic features of thyroid nodules with 3-Dimensional Ultrasound and 3-Dimensional Power Doppler Ultrasound and compare with conventional ultrasound. To assess the value of 3-Dimensional Ultrasound and 3-Dimensional Power Doppler Ultrasound in differentiating benign and malignant thyroid nodules.
Material and methods
From Mar 2008 to Apr 2009, ninety-four patients scheduled for surgical removal of the nodules were evaluated with 3D ultrasound and 3D-Power Doppler ultrasound. Of the 103 lesions, 50 lesions were benign, 53 were malignant.
In 3D ultrasound, with the mltiplanar reformation, the sonographic features of the thyroid nodules were observed for the location with the capsule, shape, margin, halo, internal texture, echogenicity, homogenicity and calcification.
In 3D power Doppler ultrasound, with the color mode, the location, quantity, formation, spatial distribution of the thyroid nodules vascular, as well as whether there was the presence of local abundant vascular in the nodules or in the perinodular area of the nodules were observed.
To analyse the features of thyroid nodules in the 3D ultrasound and 3D power Doppler ultrasound with respect to the histological results. In additional, the sensitive, specificity, PPV (positive predictive value), NPV(negative predictive value), accuracy of the 3D ultrasound and 3D power Doppler ultrasound were calculated and compared with conventional ultrasound.
Results
1. Of all the 103 lesions underwent 3D ultrasound examination, 50 (48.5%) were benign and 53 (51.5%) were malignant. The malignant lesions included 48 (90.5%) papillary thyroid carcinoma (PTC), 1 (1.9%) follicular carcinoma, 3 (5.7%) medullary thyroid carcinoma (MTC), 1 (1.9%) lymphoma. The mean size of the malignant lesions was 2.13±1.07cm (0.66cm-5.14cm) , in 73.6% of patients they were stage I. The benign lesions included 40 (80.0%) goiter, 8 (16.0%) adenoma, 1 (2.0%) Hashimoto's disease, 1 (2.0%) fibrous thyroiditis. The mean size of the benign lesions was 2.39±0.96 cm (0.78cm-5.32cm) .
2. The sonographic features of 3D ultrasound of benign lesions included regular contours (88.0%), well-defined margin (84.0%), complete and regular halo (54.0%), solid with cystic components (52.0%), iso-echogenicity (66.0%), ununiform echogenicity(72.0%) ,without calcification (64.0%) . The sonographic features of 3D ultrasound of malignant lesions included irregular contours (90.6%), ill-defined margin (47.2%), no halo (62.3%), solid (94.3%), ununiform echogenicity (90.6%), hypo-echogenicity(90.6%), microcalcification (79.2%) .
3. The sonographic features of 3D power Doppler ultrasound of benign lesions included regular (96.0%), symmetric (88.0%) vascular, the absence of the local abundant vascular in the nodules (96.0%) and in the perinodular area of the nodules(94.0%) . The sonographic features of 3D power Doppler ultrasound of malignant lesions included irregular (66.2%), asymmetric vascular (56.6%), the presence of the local abundant vascular in the nodules (54.7%) and in the perinodular area of the nodules (60.4%) .
4. The sensitivity, specificity, PPV, NPV, ACC of 3D ultrasound were 88.7%, 90.0%, 90.4%, 88.2%, 89.3%, which were superior to 2D ultrasound with the sensitivity/ specificity/PPV/NPV/ACC of 86.8%/86.0%/86.8%/86.0%/86.4%. The sensitivity, specificity, PPV, NPV, ACC of 3D power Doppler ultrasound was 83.0%, 94.0%, 93.6%, 83.9%, 90.3%, which were superior to CDFI with the sensitivity/specificity/ PPV/NPV/ACC of 75.5%/92.0%/90.9%/78.0%/83.5%.
Conclusions
There is significant difference in sonographic features between the benign and malignant thyroid lesions of 3D ultrasound and 3D power Doppler ultrasound. The sensitivity and specificity of 3D is superior to 2D ultrasound. The sensitivity and specificity of 3D power Doppler ultrasound is superior to CDFI. 3D ultrasound and 3D power Doppler ultrasound provide more information of the thyroid nodules and are of great value in diagnosing and differentiating thyroid nodules.
Part II Ultrasound-guided fine-needle aspiration and core-needle biopsy in the diagnosis of thyroid
Objective
1. Evaluate the efficacy of ultrasound-guided fine-needle aspiration (US-FNA) and core needle biopsy (US-CNB) of thyroid nodules.
2. To assess the value of Thin-Layer preparation (TP) in diagnosing thyroid disease and compared with conventional preparation (CP) .
Material and methods
175 thyroid FNA were prospectively performed on 168 patients ranging from 4 to 75 years of age.
53 thyroid CB were prospectively performed on 53 patients ranging from 13 to 74 years of age.
57 thyroid FNA were performed with TP preparation simultaneously.
The cytology and histological diagnoses were categorized into four groups: benign, malignant, suspicious, and unsatisfactory. Analysis the character of cytology of TP.
Results
1. There were 39 malignant nodules and 136 benign nodules proved by histological diagnoses and clinical follow-up. One hundred and twenty four (71%) of the aspirates were diagnosed as "benign", twenty four (14%) were diagnosed as "malignant", fourteen (8%) were diagnosed as "suspicious for malignant", thirteen (7%) were read as unsatisfactory for interpretation. Sensitivity of thyroid FNA in diagnosing thyroid malignancy relative to final histological diagnoses and clinical follow-up was 81.1%, specificity was 93.6%, accuracy was 90.7%, PPV was 78.9%, NPV was 94.4%. 7 cases was false negative. 8 cases was false positive. Bleeding was observed in 3 nodules(1.7%).
2. Sensitivity/specificity/accuracy/PPV/NPV of US-FNA in diagnosing solid thyroid nodule was 82.9%, 91.7%, 88.8%, 82.9%, 91.7%. Sensitivity/ specificity/ accuracy/PPV/NPV of US-FNA in diagnosing cyst-solid thyroid nodule was 50.0%, 96.3%, 94.6%, 33.3%, 98.1%.
3. Sensitivity/specificity/accuracy/PPV/NPV of US-FNA in diagnosing solid thyroid nodule with a diameter of 1cm or smaller was 75.0%, 96.7%, 94.1%, 75.0%, 96.7%. Sensitivity/specificity/accuracy/PPV/NPV of US-FNA in diagnosing solid thyroid nodule with a diameter larger than 1cm was 83.9%, 88.1%, 86.3%, 83.9%, 88.1%.
4. There were 22 malignant nodules and 31 benign nodules proved by histological diagnoses and clinical follow-up. Thirty five (66%) of the biopsies aspirates were diagnosed as "benign", fifteen (28%) were diagnosed as "malignant", two (4%) were diagnosed as "suspicious for malignant", one (2%) was read as unsatisfactory for interpretation. Sensitivity of thyroid FNA in diagnosing thyroid malignancy relative to final histological diagnoses and clinical follow-up was 81.0%, specificity was 100%, accuracy was 92.5%, PPV was 100%, NPV was 88.6%. Bleeding was observed in 2 nodules (3.8%).
5. The inadequate rate of TP is 8.8%, compared with conventional smears, the cytology character of TP included markedly decreased background blood cells, decreased or dense colloid, more cell shrinkage, densely stained nuclear, disruption of the cytoplasm and numerous naked nuclei.
Conclusions
1. US-FNA and US-CNB were accurate and reliable methods to diagnose thyroid nodules.
2. The specificity and PPV of CNB is a little higher than FNA. The sensitivity of FNA is a little higher than CNB. FNA is more convenient and safe, with satisfactory efficacy.
3. The sensitivity of FNA is high in diagnosing solid thyroid nodules but relatively low in diagnosing cyst-solid thyroid nodules. We should interpret the results in consideration with different clinical conditions.
4. The combination of cytological smears and histological cell block helps to detect malignant thyroid nodules.
5. Thin-layer preparation is of great value in diagnosing thyroid disease, the character of the cytology is different from conventional preparation.
引文
1. Volzke H, Ludemann J, Robinson DM, et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area [J]. Thyroid, 2003,13(8): 803-810.
2. Tan GH, Gharib. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging[J]. Ann Intern Med, 1997,126 (3):226-231.
3. International agency for Research on Cancer. Accessed at http://www-dep.iarc/fr.
4. National Cancer Institute. Surveilance, Epidemiology and End Results Program. Acessed at http://www.seer.cnacer.gov.
5. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement [J]. Radiology, 2005,237(3):794-800.
6. Ivanac G, Brkljacic B, Ivanac K,et al. Vascularisation of benign and malignant thyroid nodules: CD US evaluation[J]. Ultraschall Med, 2007,28(5):502-506.
7. Bakhshaee M, Davoudi Y, Mehrabi M, et al. Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules[J]. Laryngoscope,2008, 118(12):2182-2186.
8. Frates MC, Benson CB, Doubilet PM, et al. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules[J]? J Ultrasound Med,2003,22(2): 127-131.
9. Stacul F, Bertolotto M, De Gobbis F, et al. US, colour-Doppler US and fine-needle aspiration biopsy in the diagnosis of thyroid nodules[J]. Radiol Med,2007,112(5): 751-762.
10. Tae HJ, Lim DJ, Baek KH,et al. Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules[J]. Thyroid,2007,17(5):461 -466.
11. Moon HG, Jung EJ, Park ST, Ha WS, et al. Role of ultrasonography in predicting malignancy in patients with thyroid nodules[J]. World J Surg,2007,31(7):1410-1416.
12.杨秀贞.代丽娜.彩色多普勒血流图及能量图对甲状腺良恶性肿瘤诊断价值[J].黑龙江医学,2006,30(9):719-720.
13.Alcazar JL,Galvan R.Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometfium[J].Am J Obstet Gynecol,2009,200(1):44.e1-6.
14.Pretorius DH,Nelson TR,Baergen RN,Imaging of placental vasculature using three-dimensional ultrasound and color power Doppler:a preliminary study[J].Ultrasound Obstet Gynecol,1998,12(1):45-49.
15.Correale M,Ieva R,Di Biase M.Real-time three-dimensional echocardiography:an update[J].Eur J Intern Med,2008,19(4):241-248.
16.Surry KJ,Smith WL,Campbell LJ,The development and evaluation of a three-dimensional ultrasound-guided breast biopsy apparatus[J].Med Image Anal,2002,6(3):301-312.
17.Rotten D,Levaillant JM,Zerat L.Analysis of normal breast tissue and of solid breast masses using three-dimensional ultrasound mammography[J].Ultrasound Obstet Gynecol,1999,14(2):114-24.
18.Huang SF,Chang RF,Moon WK,et al.Analysis of tumor vascularity using three-dimensional power Doppler ultrasound images[J].IEEE Trans Med Imaging,2008,27(3):320-330.
19.Chang RF,Huang SF,Moon WK,et al.Solid breast masses:neural network analysis of vascular features at three-dimensional power Doppler US for benign or malignaht classification[J].Radiology,2007,243(1):56-62.
20.Hsiao YH,Huang YL,Liang WM,et al.Characterization of benign and malignant solid breast masses:harmonic versus nonharmonic 3D power Doppler imaging[J].Ultrasound Med Biol,2009,35(3):353-359.
21.Slapa RZ,Slowinska-Srzednicka J,Szopinski KT,et al.Gray-scale three-dimensional sonography of thyroid nodules:feasibility of the method and preliminary studies[J].Eur Radiol,2006,16(2):428-436.
22.王淑玲,蒋雪梅,刘鸿玉.彩色多普勒和三维能量成像在甲状腺弥漫性病变中的应用[J].临床超声医学杂志,2001,3(1):19-21.
23.张超学,张新书,王玲,等.甲状腺腺瘤血管结构的三维重建及血管容积指数特点分析[J].中国超声医学杂志,2005,21(3):220-223.
24.江泉,柏宁野,赵玉华,等.三维血管能量图超声在甲状腺结节诊断中的应用[J].中国超声医学杂志,2008,24(7):598-600.
25.李锐,郭燕丽,华兴,等.彩色多普勒血流图与三维彩色能量图在诊断甲状腺局限性病变中的应用价值[J].第三军医大学学报,2005,27(12):1282-1284.
26.孙霞,刘书海,张清泉,等.甲状腺肿瘤三维血管定量与病理微血管定量相关性研究[J].中国超声医学杂志,2004,20(12):891-893.
27.Slapa RZ,Slowinska-Srzednicka J,Szopinski KT,et al.Gray-scale three-dimensional sonography of thyroid nodules:feasibility of the method and preliminary studies[J].Eur Radiol,2006,16(2):428-436.
28.Gharib H,Goellner JR.Fine-needle aspiration biopsy of the thyroid:an appraisal[J].Ann Int Med,1993,118(4):282-289.
29.Amrikachi M,Ramzy I,Rubenfeld S,et al.Accuracy of fine-needle aspiration of thyroid[J].Arch Pathol Lab Med,2001,125(4):484-488.
30.Musgrave YM,Davey DD,Weeks JA,et al.Assessment of fine needle aspiration sampling techniques in thyroid nodules[J].Daign Cytopathol,1998,18(1):76-80.
31.Werga P,Wallin G,Skoog L,et al.Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management[J].World J Surg,2000,24(8):907-912.
32.Giard RW,Hermans J.Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma:an audit using a national pathology database [J].Cancer,2000,90(6):330-334.
33.Yang J,Schnadig V,Logrono R,et al.Fine-needle aspiration of thyroid nodules:a study of 4703 patients with histologic and clinical correlations[J].Cancer,2007,111(5):306-315.
34.Lee KR,Ashfaq R,Birdsong GG,et al.Comparison of conventional Papanicolaou smears and a fluid-based,thin-layer system for cervical cancer screening[J].Obstet Gynecol,1997,90(2):278-284.
35.Nassar H,Ali-Fehmi R,Madan S.Use of ThinPrep monolayer technique and cytospin preparation in urine cytology:a comparative analysis[J].Diagn Cytopathol,2003,28(3):115-118.
1. Ivanac G, Brkljacic B, Ivanac K,et al. Vascularisation of benign and malignant thyroid nodules: CD US evaluation[J]. Ultraschall Med, 2007,28(5):502-506.
2. Bakhshaee M, Davoudi Y, Mehrabi M, et al. Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules[J]. Laryngoscope, 2008,118(12):2182-2186.
3. Frates MC, Benson CB, Doubilet PM, et al. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules[J]? J Ultrasound Med,2003,22(2): 127-131.
4. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement[J]. Radiology, 2005,237(3):794-800.
5. Stacul F, Bertolotto M, De Gobbis F, et al. US, colour-Doppler US and fine-needle aspiration biopsy in the diagnosis of thyroid nodules[J]. Radiol Med,2007,112 (5):751-762.
6. Tae HJ, Lim DJ, Baek KH,et al. Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules[J]. Thyroid, 2007,17(5):461-466.
7. Moon HG, Jung EJ, Park ST, Ha WS, et al. Role of ultrasonography in predicting malignancy in patients with thyroid nodules[J]. World J Surg, 2007,31(7): 1410-1416.
8. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy [J]. J Ultrasound Med, 2004, 23(11):1455-1464.
9. Jun P, Chow LC, Jeffrey RB The sonographic features of papillary thyroid carcinomas: pictorial essay [J]. Ultrasound Q, 2005,21(1):39-45.
10. Komolafe F.Radiological patterns and significance of thyroid calcification [J]. Clin Radiol, 1981,32(5):571-575.
11. Chan BK, Desser TS, McDougall IR,et al. Common and uncommon sonographic features of papillary thyroid carcinoma [J]. J Ultrasound Med,2003,22(10):1083-1090.
12. Fenster A, Downey DB, Cardinal HN. Three-dimensional ultrasound imaging[J].Phys Med Biol, 2001,46(5):R67-99.
13.杨秀贞.代丽娜.彩色多普勒血流图及能量图对甲状腺良恶性肿瘤诊断价值[J].黑龙江医学,2006,30(9):719-720.
14.Juan Rosai.Rosai and Ackerman's Surgical Pathology.9th[M].Mosby,2004,515-541
15.Senchenkov A,Staren ED.Ultrasound in head and neck surgery:thyroid,parathyroid,and cervical lymph nodes[J].Surg Clin North Am,2004,84(4):973-1000.
16.Chammas MC,Gerhard R,de Oliveira IR,et al.Thyroid nodules:evaluation with power Doppler and duplex Doppler ultrasound[J].Otolaryngol Head Neck Surg,2005,132(6):874-882
17.周庚寅,觉道健一.甲状腺病理与临床[M].北京:人民卫生出版社,2005,138-148.
18.Lyshchik A,Drozd V,Demidchik Y,et al.Diagnosis of thyroid cancer in children:value of gray-scale and power doppler US[J].Radiology,2005,235(2):604-613.
19.汪娜,姚克纯,刘淑萍,等.甲状腺癌的超声表现及病理学基础的对比分析[J].医学影像学杂志,2008,18(4):402-404.
20.Carney JA,Hirokawa M,Lloyd RV,Hyalinizing trabecular tumors of the thyroid gland are almost all benign[J].Am J Surg Pathol,2008,32(12):1877-1889.
21.Mitchell JC,Parangi S.Angiogenesis in benign and malignant thyroid disease[J].Thyroid,2005,15(6):494-510.
22.江泉,柏宁野,赵玉华,等.三维血管能量图超声在甲状腺结节诊断中的应用[J].中国超声医学杂志,2008,24(7):598-600.
23.Sehgal CM,Arger PH,Rowling SE,et al.Quantitative vascularity of breast masses by Doppler imaging:regional variations and diagnostic implications[J].J Ultrasound Med,2000,19(7):427-440.
24.苏一巾,顾继英,杜联芳.三维超声成像技术在甲状腺良恶性结节鉴别诊断中的应用[J].实用诊断与治疗杂志,2008,22(2):84-86.
25.Nelson TR,Pretorius DH,Hull A,et al.Sources and impact of artifacts on clinical three-dimensional ultrasound imaging[J].Ultrasound Obstet Gynecol,2000,16(4):374-383.
1.Tan GH,Gharib.Thyroid incidentalomas:management approaches to nonpalpable nodules discovered incidentally on thyroid imaging[J].Ann Intern Med,1997,126(3):226-231.
2.McKee G.The role of fine needle aspiration cytology in the diagnosis of thyroid lesions[J].J R Soc Med,1998,91(Suppl 33):28-32.
3.Gharib H,Papini E,Valcavi R,et al.American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J].Endocr Pract,2006,12(1):63-102.
4.Naik KS,Bury RF.Imaging the thyroid[J].Clin Radiol,1998,53(9):630-639.
5.Gharib H,Goellner JR.Fine-needle aspiration biopsy of the thyroid:an appraisal[J].Ann Int Med,1993,118(4):282-289.
6.Amrikachi M,Ramzy I,Rubenfeld S,et al.Accuracy of fine-needle aspiration of thyroid[J].Arch Pathol Lab Med,2001,125(4):484-488.
7.Musgrave YM,Davey DD,Weeks JA,et al.Assessment of fine needle aspiration sampling techniques in thyroid nodules[J].Daign Cytopathol,1998,18(1):76-80.
8.Werga P,Wallin G,Skoog L,et al.Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management[J].World J Surg,2000,24(8):907-912.
9.Giard RW,Hermans J.Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma:an audit using a national pathology database[J].Cancer,2000,90(6):330-334.
10.Yang J,Schnadig V,Logrono R,et al.Fine-needle aspiration of thyroid nodules:a study of 4703 patients with histologic and clinical correlations[J].Cancer,2007,111(5):306-315.
11.任玉波,马青松,梁风泉.细针吸取细胞学诊断甲状腺结节的探讨[J].中国肿瘤临床,2003,30(2):112-115.
12.Hawkins F,Bellido D,Bernal C,et al.Fine needle aspiration biopsy in the diagnosis of thyroid cancer and thyroid disease[J].Cancer,1987,59(6):1206-1209.
13.Burch HB,Burman KD,Reed LH,et al.Fine needle aspiration of thyroid nodules.Determinants of insufficiency rate and malignancy yield at thyroidectomy[J].Acta Cytol,1996,40(6):1176-1183.
14.Ravetto C,Colombo L,Dottorini ME.Usefulness of fine needle aspiration in the diagnosis of thyroid carcinoma:a retrospective study in 37,895 patients[J].Cancer,2000,90(6):357-363.
15.Mehrotra P,Viswanathan H,Johnson SJ,et al.Ultrasound guidance improves the adequacy of our preoperative thyroid cytology but not its accuracy[J].Cytopathology,2006,17(4):137-144.
16.Braga M,Cavalcanti TC,Collaco LM,et al.Efficacy of ultrasound- guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules[J].J Clin Endocrinol Metab,2001,86(9):4089-4091.
17.刘春波,高晓虹,王俊峰等.超声引导及触诊下细针穿刺活检对甲状腺结节的诊断对比观察[J].中国超声诊断杂志,2004,5(4):249-251.
18.Papini E,Guglielmi R,Bianchini A,et al.Risk of malignancy in nonpalpable thyroid nodules:predictive value of ultrasound and color-Doppler features[J].J Clin Endocrinol Metab,2002,87(5):1941-1946.
19.Sangalli G,Serio G,Zampatti C,et al.Fine needle aspiration cytology of the thyroid:a comparison of 5469 cytological and final histological diagnoses[J].Cytopathology,2006,17(5):245-250.
20.Cappelli C,Castellano M,Pirola I,et al.The predictive value of ultrasound findings in the management of thyroid nodules[J].QJM,2007,100(1):29-35.
21.Screaton NJ,Berman LH,Grant JW.US-guided core-needle biopsy of the thyroid gland[J].Radiology,2003,226(3):827-832.
22.Harvey JN,Parker D,De P,et al.Sonographically guided core biopsy in the assessment of thyroid nodules[J].J Clin Ultrasound,2005,33(2):57-62.
23.Taki S,Kakuda K,Kakuma K,et al.Thyroid nodules:evaluation with US-guided core biopsy with an automated biopsy gun[J].Radiology,1997,202(3):874-877.
24.Quinn SF,Nelson HA,Demlow TA.Thyroid biopsies:fine-needle aspiration biopsy versus spring-activated core biopsy needle in 102 patients[J].J Vasc Interv Radiol,1994,5(4):619-623.
25.Baloch ZW,Gupta PK,Yu GH,Sack MJ,et al.Follicular variant of papillary carcinoma.Cytologic and histologic correlation[J].Am J Clin Pathol,1999,111(2):216-222.
26.Kaneko C,Shamoto M,Niimi H,et al.Studies on intranuclear inclusions and nuclear grooves in papillary thyroid cancer by light,scanning electron and transmission electron microscopy[J].Acta Cytol,1996,40(3):417-422.
27.Das A,Gupta SK,Srinivasan R,et al.Atypical cytologic features of medullary carcinoma of the thyroid[J].Acta Cytol,1992,36:137-140.
28.Doria R,Jekel JF,Cooper DL.Thyroid lymphoma.The case for combined modality therapy[J].Cancer,1994,73(1):200-206.
29.Tsang RW,Gospodarowicz MK,Sutcliffe SB,et al.Non-Hodgkin's lymphoma of the thyroid gland:prognostic factors and treatment outcome.The Princess Margaret Hospital Lymphoma Group[J].Int J Radiat Oncol Biol Phys,1993,27(3):599-604.
30.Ohye H,Fukata S,Hirokawa M.Malignant lymphoma of the thyroid[J].Nippon Rinsho,2007,65(11):2092-2098.
31.Yang H,Li J,Shen T.Primary T-cell lymphoma of the thyroid:case report and review of the literature[J].Med Oncol,2008,25(4):462-466.
32.Pedersen RK,Pedersen NT.Primary non-Hodgkin's lymphoma of the thyroid gland:a population based study[J].Histopathology,1996,28(1):25-32.
33.Derringer GA,Thompson LD,Frommelt RA,et al.Malignant lymphoma of the thyroid gland:a clinicopathologic study of 108 cases[J].Am J Surg Pathol,2000,24(5):623-639.
34.周庚寅,觉道健一.甲状腺病理与临床[M].北京:人民卫生出版社2005:193-194.
35.Pasieka JL.Hashimoto's disease and thyroid lymphoma:role of the surgeon[J].World J Surg,2000,24(8):966-970.
36.Cha C,Chen H,Westra WH,et al.Primary Thyroid Lymphoma:Can the Diagnosis Be Made Solely by Fine-Needle Aspiration[J]? Ann Surg Oncol,2002,9(3):298-302.
37.Quinn SF,Sheley RC,Nelson HA,et al.The role of percutaneous needle biopsies in the original diagnosis of lymphoma:a prospective evaluation[J].J Vasc Interv Radiol,1995,6(6):947-952.
38.Riazmontazer N,Bedayat G.Psammoma bodies in fine needle aspirates from thyroids containing nontoxic hyperplastic nodular goiters[J].Acta Cytol,1991,35(5):563-566.
39.Baloch ZW,Fleisher S,LiVolsi VA,et al.Diagnosis of "follicular neoplasm":a gray zone in thyroid fine-needle aspiration cytology[J].Diagn Cytopathol,2002,26(1):41-44.
40.周庚寅,觉道健一.甲状腺病理与临床[M].北京:人民卫生出版社,2005:240-241.
41.Kim DW,Lee EJ,Kim SH,et al.Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules:comparison in efficacy according to nodule size[J].Thyroid,2009,19(1):27-31.
42.Frates MC,Benson CB,Doubilet PM,et al.Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography[J].J Clin Endocrinol Metab,2006,91(9):3411-3417.
43.Yuan WH,Chiou HJ,Chou YH,et al.Gray-scale and color Doppler ultrasonographic manifestations of papillary thyroid carcinoma:analysis of 51cases[J].Clin Imaging,2006,30(6):394-401.
44.Choi KU,Kim JY,Park DY,et al.Recommendations for the management of cystic thyroid nodules[J].ANZ J Surg,2005,75(7):537-541.
45.Lee MJ,Kim EK,Kwak JY,et al.Partially cystic thyroid nodules on ultrasound:probability of malignancy and sonographic differentiation[J].Thyroid,2009,19(4):341-346.
46.Lin JD,Hsuen C,et al.Cystic change in thyroid cancer[J].ANZ J Surg,2007,77(6):450-454.
47.Lee KR,Ashfaq R,Birdsong GG,et al.Comparison of conventional Papanicolaou smears and a fluid-based,thin-layer system for cervical cancer screening[J].Obstet Gynecol,1997,90(2):278-284.
48.Nassar H,Ali-Fehmi R,Madan S.Use of ThinPrep monolayer technique and cytospin preparation in urine cytology:a comparative analysis[J].Diagn Cytopathol,2003,28(3):115-118.
49.Parfitt JR,McLachlin CM,Weir MM.Comparison of ThinPrep and conventional smears in salivary gland fine-needle aspiration biopsies[J].Cancer,2007,111(2):123-129.
50. Veneti S, Daskalopoulou D, Zervoudis S,et al.Liquid-based cytology in breast fine needle aspiration. Comparison with the conventional smear[J]. Acta Cytol,2003, 47(2):188-192.
51. Michael CW, Pang Y, Pu RT, Hasteh F, Griffith KA. Cellular adequacy for thyroid aspirates prepared by ThinPrep: how many cells are needed[J]?Diagn Cytopathol,2007,35(12):792-797.
52. Fadda G, Rossi ED, Raffaelli M, Fine-needle aspiration biopsy of thyroid lesions processed by thin-layer cytology: one-year institutional experience with histologic correlation[J].Thyroid, 2006,16(10):975- 981.
53. Witt RL.A comparison of the results of monolayer versus smear cytopreparatory techniques for fine-needle aspiration in 100 consecutive patients undergoing thyroidectomy: a surgeon's perspective [J].Otolaryngol Head Neck Surg,2004, 131(6):964-967.
54. Frost AR, Sidawy MK, Ferfelli M, Utility of thin-layer preparations in thyroid fine-needle aspiration: diagnostic accuracy, cytomorphology, and optimal sample preparation[J]. Cancer, 1998,84(1): 17-25.
55. Nguyen GK, Ginsberg J, Crockford PM. Fine-needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules [J].Pathol Annu,1991,25(1):63- 91.
56. Hor T, Lahiri SW. Bilateral Thyroid Hematomas after Fine-Needle Aspiration Causing Acute Airway Obstruction [J].Thyroid,2008,18(5):567-569.
1.Wild JJ,Reid JM.Application of echo-ranging techniques to the determination of the structure of biological tissues[J].Science,1952,115(2983):226-230.
2.Cardinal HN,Gill JD,Fenster A.Analysis of geometrical distortion and statistical variance in length,area,and volume in a linearly scanned 3-D ultrasound image[J].IEEE Trans Med Imaging,2000,19(6):632-651.
3.Smith SW,Trahey GE,von Ramm OT.Two-dimensional arrays for medical ultrasound[J].Ultrason Imaging,1992,14(3):213-233.
4.焦明德,蔡爱露,吴长君,等主编.实用三维超声诊断学[M].北京:军事医学出版社,2003,9-13.
5.Robb RA.Three-dimensional Biomedical Imaging:Principles and Practice [M].1995(New York:VCH)
6.Gerscovich EO,Greenspan A,Cronan MS,et al.Three-dimensional sonographic evaluation of developmental dysplasia of the hip:preliminary findings[J].Radiology,1994,190(2):407-410.
7.Blake CC,Elliot TL,Slomka PJ,et al.Variability and accuracy of measurements of prostate brachytherapy seed position in vitro using three-dimensional ultrasound:an intra- and inter-observer study[J].Med Phys,2000,27(12):2788- 2795.
8.Guo Z,Fenster A.Three-dimensional power Doppler imaging:a phantom study to quantify vessel stenosis[J].Ultrasound Med Biol,1996,22(8):1059-1069.
9.杨秀贞.代丽娜.彩色多普勒血流图及能量图对甲状腺良恶性肿瘤诊断价值[J].黑龙江医学,2006,30(9):719-720.
10.Alcazar JL,Galvan R.Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometrium[J].Am J Obstet Gynecol,2009,200(1):44.el-6.
11.Pretorius DH,Nelson TR,Baergen RN,Imaging of placental vasculature using three-dimensional ultrasound and color power Doppler:a preliminary study[J].Ultrasound Obstet Gynecol,1998,12(1):45-49.
12.Correale M,Ieva R,Di Biase M.Real-time three-dimensional echocardiography:an update[J].Eur J Intern Med,2008,19(4):241-248.
13.Hotta N,Ayada M,Okumura A,et al.Usefulness of live 3D echocardiography during radiofrequency ablation in a case of hepatocellular carcinoma[J]. Clin Imaging, 2007, 31(4):283-286.
14. Xu HX, Yin XY, Lu MD, et al. Usefulness of three-dimensional sonography in procedures of ablation for liver cancers: initial experience[J]. J Ultrasound Med,2003,22(11):1239-1247.
15. Mehta SS, Azzouzi AR, Hamdy FC.Three dimensional ultrasound and prostate cancer[J].World J Urol,2004,22(5):339-345.
16. Surry KJ, Smith WL, Campbell LJ,The development and evaluation of a three-dimensional ultrasound-guided breast biopsy apparatus[J]. Med Image Anal,2002, 6(3):301-312.
17. Rotten D, Levaillant JM, Zerat L. Analysis of normal breast tissue and of solid breast masses using three-dimensional ultrasound mammography[J]. Ultrasound Obstet Gynecol, 1999,14(2): 114-124.
18. Huang SF, Chang RF, Moon WK, et al. Analysis of tumor vascularity using three-dimensional power Doppler ultrasound images[J]. IEEE Trans Med Imaging,2008,27(3):320-330.
19. Chang RF, Huang SF, Moon WK, et al. Solid breast masses: neural network analysis of vascular features at three-dimensional power Doppler US for benign or malignant classification [J].Radiology,2007,243(1): 56-62.
20. Hsiao YH, Huang YL, Liang WM, et al. Characterization of benign and malignant solid breast masses: harmonic versus nonharmonic 3D power Doppler imaging[J]. Ultrasound Med Biol,2009,35(3):353-359.
21. Lyshchik A, Drozd V, Schloegl S, et al. Three-dimensional ultrasonography for volume measurement of thyroid nodules in children[J]. J Ultrasound Med, 2004,23(2):247-254.
22. Lyshchik A, Drozd V, Reiners C. Accuracy of three-dimensional ultrasound for thyroid volume measurement in children and adolescents.Thyroid,2004,14 (2):113-120.
23. Sonographic measurement of thyroid gland volume: A comparison of 2D and 3D ultrasound[J].Radiology,2005,11(4):242-248.
24. Andermann P, Schlogl S, Mader U, et al.Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound[J]. Nuklearmedizin,2007,46(1): 1 -7.
25. Ng E, Chen T, Lam R,Three-dimensional ultrasound measurement of thyroid volume in asymptomatic male Chinese[J]. Ultrasound Med Biol, 2004,30(11): 1427-1433.
26.Slapa RZ,Slowinska-Srzednicka J,Szopinski KT,et al.Gray-scale three-dimensional sonography of thyroid nodules:feasibility of the method and preliminary studies[J].Eur Radiol,2006,16(2):428-436.
27.李建国,强沁晨,刘月洁,等.甲状腺血管能量三维超声技术相关技巧探讨[J].中国医学影像技术,2001,17(2):139-140.
28.王淑玲,蒋雪梅,刘鸿玉.彩色多普勒和三维能量成像在甲状腺弥漫性病变中的应用[J].临床超声医学杂志,2001,3(1):19-21.
29.张超学,张新书,王玲,等.甲状腺腺瘤血管结构的三维重建及血管容积指数特点分析[J].中国超声医学杂志,2005,21(3):220-223.
30.江泉,柏宁野,赵玉华,等.三维血管能量图超声在甲状腺结节诊断中的应用[J].中国超声医学杂志,2008,24(7):598-600.
31.李锐,郭燕丽,华兴,等.彩色多普勒血流图与三维彩色能量图在诊断甲状腺局限性病变中的应用价值[J].第三军医大学学报,2005,27(12):1282-1284.
32.孙霞,刘书海,张清泉,等.甲状腺肿瘤三维血管定量与病理微血管定量相关性研究[J].中国超声医学杂志,2004,20(12):891-893.
1.Singer PA,Cooper DS,Daniels GH,et al.Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer[J].American Thyroid Association.Arch Intern Med,1996,156(19):2165-2172.
2.Wong CK,Wheeler MH.Thyroid nodules:rational management[J].World J Surg,2000,24(8):934-941.
3.Gharib H,Papini E,Paschke R.Thyroid nodules:a review of current guidelines,practices,and prospects[J].Eur J Endocrinol,2008,159(5):493-505.
4.Ljung BM,Langer J,Mazzaferri EL,et al.Training,credentialing and re-credentialing for the performance of a thyroid FNA:a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference[J].Diagn Cytopathol,2008,36(6):400-406.
5.Marqusee E,Benson CB,Frates MC,et al.Usefulness of ultrasonography in the management of nodular thyroid disease[J].Ann Intern Med,2000,133(9):696-700.
6.Mehrotra P,Viswanathan H,Johnson SJ,et al.Ultrasound guidance improves the adequacy of our preoperative thyroid cytology but not its accuracy[J].Cytopathology,2006,17(4):137-144.
7.Braga M,Cavalcanti TC,Collaco LM,et al.Efficacy of ultrasound-guided fine-needle aspiration bigpsy in the diagnosis of complex thyroid nodules[J].J Clin Endocrinol Metab,2001,86(9):4089-4091.
8.刘春波,高晓虹,王俊峰等.超声引导及触诊下细针穿刺活检对甲状腺结节的诊断对比观察[J].中国超声诊断杂志,2004,5(4):249-251.
9.Cesur M,Corapcioglu D,Bulut S,et al.Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules[J].Thyroid,2006,16(6):555-561.
10.Kollur SM,El Sayed S,El Hag IA.Follicular thyroid lesions coexisting with Hashimoto's thyroiditis:incidence and possible sources of diagnostic errors[J].Diagn Cytopathol,2003,28(1):35 -38.
11.Nguyen GK,Ginsberg J,Crockford PM,et al.Hashimoto's thyroiditis:cytodiagnostic accuracy and pitfalls[J].Diagn Cytopathol,1997,16(6):531-536.
12.Granter SR,Cibas ES.Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism[J]. Am J Clin Pathol, 1997,107(1):20-25.
13. Orell SR, Philips J. Broadsheet number 57: problems in fine needle biopsy of the thyroid[J]. Pathology, 2000, 32(3): 191-198.
14. Papanicolaou Society of Cytopathology Task Force on Standard of Practice (Suen KC, Chair): Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules[J]. Diagn Cytopathol, 1996, 15(1): 84-89.
15. Zhu W, Michael CW. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases[J]. Diagn Cytopathol, 2007,35(3): 183-186.
16. Redman R, Zalaznick H, Mazzaferri EL,et al. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules[J]. Thyroid, 2006,16(1):55-60.
17. Hegedus L. Clinical practice. The thyroid nodule[J]. N Engl J Med,2004,351(17): 1764-1771.
18. Kelly NP, Lim JC, DeJong S, et al. Specimen adequacy and diagnostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules[J].Diagn Cytopathol, 2006,34(3):188-191.
19. Layfield LJ, Wax T, Jones C Cytologic distinction of goiterous nodules from morphologically normal thyroid: analyses of cytomorphologic features[J]. Cancer, 2003,99(4):217-222.
20. Anderson SR, Mandel S, LiVolsi VA, et al. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease[J]? Diagn Cytopathol, 2004,31(1):64-67.
21. Kim WB, Han SM, Kim TY, et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease[J]. Clin Endocrinol,2004,60(6):719-725.
22. Kumar N, Ray C, Jain S. Aspiration cytology of Hashimoto's thyroiditis in an endemic area[J]. Cytopathology, 2002,13(1):31-39.
23. MacDonald L, Yazdi HM. Fine needle aspiration biopsy of Hashimoto's thyroiditis[J]. Sources of diagnostic error. Acta Cytol, 1999,43(3):400-406.
24. Baloch ZW, Fleisher S, LiVolsi VA, Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology[J]. Diagn Cytopathol, 2002,26(1):41-44.
25. Pu RT, Yang J, Wasserman PG, et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration[J]? Diagn Cytopathol, 2006,34(5):330-334.
26. Clary KM, Condel JL, Liu Y, et al. Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland[J].Acta Cytol, 2005,49(4):378-382.
27. Elliott DD, Pitman MB, Bloom L.et al. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis[J]. Cancer, 2006 25,108(2):102-109.
28. Das DK, Mallik MK, Sharma P, et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant[J]. Acta Cytol, 2004,48(3):325-336.
29. Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens[J]. Am J Clin Pathol, 2006,125(Suppl):S135-144
30. Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma[J]. Endocr Pathol, 2006,17(1):1-18.
31. Zacks JF, de las Morenas A, Beazley RM Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid[J]. Diagn Cytopathol, 1998,18(2):87-90.
32. Solomon A, Gupta PK, LiVolsi VA, et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens[J]. Diagn Cytopathol, 2002,27(3): 143-148.
33. Collins BT, Cramer HM, Tabatowski K, Fine needle aspiration of medullary carcinoma of the thyroid. Cytomorphology, immunocytochemistry and electron microscopy[J]. Acta Cytol, 1995,39(5):920-930.
34. Cha C, Chen H, Westra WH, Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration[J]? Ann Surg Oncol, 2002,9(3):298-302.
35. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal[J]. Ann Intern Med, 1993,118(4):282-289.
36. Nguyen GK, Ginsberg J, Crockford PM. Fine-needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules [J]. Pathol Annu, 1991, 25(1):63-91.
37. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2006,16(2):109-142.
38. Marqusee E, Benson CB, Frates MC, et al Usefulness of ultrasonography in the management of nodular thyroid disease[J]. Ann Intern Med, 2000,133(9):696-700.
39. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features[J]. J Clin Endocrinol Metab, 2002 ,87(5): 1941-1946.
40. Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy[J]. J Ultrasound Med, 2003,22(10): 1027-1031.
41. Ylagan LR, Farkas T, Dehner LP. Fine needle aspiration of the thyroid: a cytohistologic correlation and study of discrepant cases[J]. Thyroid, 2004,14(1): 35-41.
42. Orlandi A, Puscar A, Capriata E, et al. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up[J]. Thyroid, 2005,15(3):274-278.
43. Wemeau JL, Caron P, Schvartz C, Schlienger JL, et al.Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group[J]. J Clin Endocrinol Metab, 2002,87(11):4928-3494.
44. Yang J, Schnadig V, Logrono R, Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations[J].Cancer,2007,111(5):306-315.
45. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid[J]. AJR Am J Roentgenol, 2002,178(3):687-691.
46. Baloch ZW, LiVolsi VA, Asa SL, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference[J]. Diagn Cytopathol, 2008,36(6):425-437.
47. Gharib H, Papini E, Valcavi R, et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J].Endocr Pract,2006,12(1):63-102.
48. Malle D, Valeri RM, Pazaitou-Panajiotou K, et al. Use of a thin-layer technique in thyroid fine needle aspiration[J]. Acta Cytol, 2006,50(1):23-27.
49. Saggiorato E, De Pompa R, Volante M, et al. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application[J]. Endocr Relat Cancer, 2005,12(2):305-317.
50. Baloch ZW, Sack MJ, Yu GH, et al. Fine-needle aspiration of thyroid: an institutional experience[J]. Thyroid, 1998,8(7):565-569.
51. Katoh R, Miyagi E, Nakamura N, Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas[J]. Hum Pathol, 2000,31(3):386-393.
52. Nikiforova MN, Biddinger PW, Caudill CM, et al. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses[J]. Am J Surg Pathol, 2002,26(8): 1016-1623.
53. Cheung CC, Carydis B, Ezzat S, et al. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer[J]. J Clin Endocrinol Metab. 2001,86(5):2187-2190.
54. Papotti M, Volante M, Saggiorato E,et al. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma[J]. Eur J Endocrinol, 2002,147(4):515-521.
55. Saggiorato E, Cappia S, De Giuli P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma[J]. J Clin Endocrinol Metab, 2001,86(11):5152-5158.
56. Takano T, Miyauchi A, Matsuzuka F, et al. Diagnosis of thyroid malignant lymphoma by reverse transcription-polymerase chain reaction detecting the monoclonality of immunoglobulin heavy chain messenger ribonucleic acid[J]. J Clin Endocrinol Metab, 2000,85(2):671-675.
2. Tan GH, Gharib. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging[J]. Ann Intern Med, 1997,126 (3):226-231.
3. International agency for Research on Cancer. Accessed at http://www-dep.iarc/fr.
4. National Cancer Institute. Surveilance, Epidemiology and End Results Program. Acessed at http://www.seer.cnacer.gov.
5. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement [J]. Radiology, 2005,237(3):794-800.
6. Ivanac G, Brkljacic B, Ivanac K,et al. Vascularisation of benign and malignant thyroid nodules: CD US evaluation[J]. Ultraschall Med, 2007,28(5):502-506.
7. Bakhshaee M, Davoudi Y, Mehrabi M, et al. Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules[J]. Laryngoscope,2008, 118(12):2182-2186.
8. Frates MC, Benson CB, Doubilet PM, et al. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules[J]? J Ultrasound Med,2003,22(2): 127-131.
9. Stacul F, Bertolotto M, De Gobbis F, et al. US, colour-Doppler US and fine-needle aspiration biopsy in the diagnosis of thyroid nodules[J]. Radiol Med,2007,112(5): 751-762.
10. Tae HJ, Lim DJ, Baek KH,et al. Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules[J]. Thyroid,2007,17(5):461 -466.
11. Moon HG, Jung EJ, Park ST, Ha WS, et al. Role of ultrasonography in predicting malignancy in patients with thyroid nodules[J]. World J Surg,2007,31(7):1410-1416.
12.杨秀贞.代丽娜.彩色多普勒血流图及能量图对甲状腺良恶性肿瘤诊断价值[J].黑龙江医学,2006,30(9):719-720.
13.Alcazar JL,Galvan R.Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometfium[J].Am J Obstet Gynecol,2009,200(1):44.e1-6.
14.Pretorius DH,Nelson TR,Baergen RN,Imaging of placental vasculature using three-dimensional ultrasound and color power Doppler:a preliminary study[J].Ultrasound Obstet Gynecol,1998,12(1):45-49.
15.Correale M,Ieva R,Di Biase M.Real-time three-dimensional echocardiography:an update[J].Eur J Intern Med,2008,19(4):241-248.
16.Surry KJ,Smith WL,Campbell LJ,The development and evaluation of a three-dimensional ultrasound-guided breast biopsy apparatus[J].Med Image Anal,2002,6(3):301-312.
17.Rotten D,Levaillant JM,Zerat L.Analysis of normal breast tissue and of solid breast masses using three-dimensional ultrasound mammography[J].Ultrasound Obstet Gynecol,1999,14(2):114-24.
18.Huang SF,Chang RF,Moon WK,et al.Analysis of tumor vascularity using three-dimensional power Doppler ultrasound images[J].IEEE Trans Med Imaging,2008,27(3):320-330.
19.Chang RF,Huang SF,Moon WK,et al.Solid breast masses:neural network analysis of vascular features at three-dimensional power Doppler US for benign or malignaht classification[J].Radiology,2007,243(1):56-62.
20.Hsiao YH,Huang YL,Liang WM,et al.Characterization of benign and malignant solid breast masses:harmonic versus nonharmonic 3D power Doppler imaging[J].Ultrasound Med Biol,2009,35(3):353-359.
21.Slapa RZ,Slowinska-Srzednicka J,Szopinski KT,et al.Gray-scale three-dimensional sonography of thyroid nodules:feasibility of the method and preliminary studies[J].Eur Radiol,2006,16(2):428-436.
22.王淑玲,蒋雪梅,刘鸿玉.彩色多普勒和三维能量成像在甲状腺弥漫性病变中的应用[J].临床超声医学杂志,2001,3(1):19-21.
23.张超学,张新书,王玲,等.甲状腺腺瘤血管结构的三维重建及血管容积指数特点分析[J].中国超声医学杂志,2005,21(3):220-223.
24.江泉,柏宁野,赵玉华,等.三维血管能量图超声在甲状腺结节诊断中的应用[J].中国超声医学杂志,2008,24(7):598-600.
25.李锐,郭燕丽,华兴,等.彩色多普勒血流图与三维彩色能量图在诊断甲状腺局限性病变中的应用价值[J].第三军医大学学报,2005,27(12):1282-1284.
26.孙霞,刘书海,张清泉,等.甲状腺肿瘤三维血管定量与病理微血管定量相关性研究[J].中国超声医学杂志,2004,20(12):891-893.
27.Slapa RZ,Slowinska-Srzednicka J,Szopinski KT,et al.Gray-scale three-dimensional sonography of thyroid nodules:feasibility of the method and preliminary studies[J].Eur Radiol,2006,16(2):428-436.
28.Gharib H,Goellner JR.Fine-needle aspiration biopsy of the thyroid:an appraisal[J].Ann Int Med,1993,118(4):282-289.
29.Amrikachi M,Ramzy I,Rubenfeld S,et al.Accuracy of fine-needle aspiration of thyroid[J].Arch Pathol Lab Med,2001,125(4):484-488.
30.Musgrave YM,Davey DD,Weeks JA,et al.Assessment of fine needle aspiration sampling techniques in thyroid nodules[J].Daign Cytopathol,1998,18(1):76-80.
31.Werga P,Wallin G,Skoog L,et al.Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management[J].World J Surg,2000,24(8):907-912.
32.Giard RW,Hermans J.Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma:an audit using a national pathology database [J].Cancer,2000,90(6):330-334.
33.Yang J,Schnadig V,Logrono R,et al.Fine-needle aspiration of thyroid nodules:a study of 4703 patients with histologic and clinical correlations[J].Cancer,2007,111(5):306-315.
34.Lee KR,Ashfaq R,Birdsong GG,et al.Comparison of conventional Papanicolaou smears and a fluid-based,thin-layer system for cervical cancer screening[J].Obstet Gynecol,1997,90(2):278-284.
35.Nassar H,Ali-Fehmi R,Madan S.Use of ThinPrep monolayer technique and cytospin preparation in urine cytology:a comparative analysis[J].Diagn Cytopathol,2003,28(3):115-118.
1. Ivanac G, Brkljacic B, Ivanac K,et al. Vascularisation of benign and malignant thyroid nodules: CD US evaluation[J]. Ultraschall Med, 2007,28(5):502-506.
2. Bakhshaee M, Davoudi Y, Mehrabi M, et al. Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules[J]. Laryngoscope, 2008,118(12):2182-2186.
3. Frates MC, Benson CB, Doubilet PM, et al. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules[J]? J Ultrasound Med,2003,22(2): 127-131.
4. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement[J]. Radiology, 2005,237(3):794-800.
5. Stacul F, Bertolotto M, De Gobbis F, et al. US, colour-Doppler US and fine-needle aspiration biopsy in the diagnosis of thyroid nodules[J]. Radiol Med,2007,112 (5):751-762.
6. Tae HJ, Lim DJ, Baek KH,et al. Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules[J]. Thyroid, 2007,17(5):461-466.
7. Moon HG, Jung EJ, Park ST, Ha WS, et al. Role of ultrasonography in predicting malignancy in patients with thyroid nodules[J]. World J Surg, 2007,31(7): 1410-1416.
8. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy [J]. J Ultrasound Med, 2004, 23(11):1455-1464.
9. Jun P, Chow LC, Jeffrey RB The sonographic features of papillary thyroid carcinomas: pictorial essay [J]. Ultrasound Q, 2005,21(1):39-45.
10. Komolafe F.Radiological patterns and significance of thyroid calcification [J]. Clin Radiol, 1981,32(5):571-575.
11. Chan BK, Desser TS, McDougall IR,et al. Common and uncommon sonographic features of papillary thyroid carcinoma [J]. J Ultrasound Med,2003,22(10):1083-1090.
12. Fenster A, Downey DB, Cardinal HN. Three-dimensional ultrasound imaging[J].Phys Med Biol, 2001,46(5):R67-99.
13.杨秀贞.代丽娜.彩色多普勒血流图及能量图对甲状腺良恶性肿瘤诊断价值[J].黑龙江医学,2006,30(9):719-720.
14.Juan Rosai.Rosai and Ackerman's Surgical Pathology.9th[M].Mosby,2004,515-541
15.Senchenkov A,Staren ED.Ultrasound in head and neck surgery:thyroid,parathyroid,and cervical lymph nodes[J].Surg Clin North Am,2004,84(4):973-1000.
16.Chammas MC,Gerhard R,de Oliveira IR,et al.Thyroid nodules:evaluation with power Doppler and duplex Doppler ultrasound[J].Otolaryngol Head Neck Surg,2005,132(6):874-882
17.周庚寅,觉道健一.甲状腺病理与临床[M].北京:人民卫生出版社,2005,138-148.
18.Lyshchik A,Drozd V,Demidchik Y,et al.Diagnosis of thyroid cancer in children:value of gray-scale and power doppler US[J].Radiology,2005,235(2):604-613.
19.汪娜,姚克纯,刘淑萍,等.甲状腺癌的超声表现及病理学基础的对比分析[J].医学影像学杂志,2008,18(4):402-404.
20.Carney JA,Hirokawa M,Lloyd RV,Hyalinizing trabecular tumors of the thyroid gland are almost all benign[J].Am J Surg Pathol,2008,32(12):1877-1889.
21.Mitchell JC,Parangi S.Angiogenesis in benign and malignant thyroid disease[J].Thyroid,2005,15(6):494-510.
22.江泉,柏宁野,赵玉华,等.三维血管能量图超声在甲状腺结节诊断中的应用[J].中国超声医学杂志,2008,24(7):598-600.
23.Sehgal CM,Arger PH,Rowling SE,et al.Quantitative vascularity of breast masses by Doppler imaging:regional variations and diagnostic implications[J].J Ultrasound Med,2000,19(7):427-440.
24.苏一巾,顾继英,杜联芳.三维超声成像技术在甲状腺良恶性结节鉴别诊断中的应用[J].实用诊断与治疗杂志,2008,22(2):84-86.
25.Nelson TR,Pretorius DH,Hull A,et al.Sources and impact of artifacts on clinical three-dimensional ultrasound imaging[J].Ultrasound Obstet Gynecol,2000,16(4):374-383.
1.Tan GH,Gharib.Thyroid incidentalomas:management approaches to nonpalpable nodules discovered incidentally on thyroid imaging[J].Ann Intern Med,1997,126(3):226-231.
2.McKee G.The role of fine needle aspiration cytology in the diagnosis of thyroid lesions[J].J R Soc Med,1998,91(Suppl 33):28-32.
3.Gharib H,Papini E,Valcavi R,et al.American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J].Endocr Pract,2006,12(1):63-102.
4.Naik KS,Bury RF.Imaging the thyroid[J].Clin Radiol,1998,53(9):630-639.
5.Gharib H,Goellner JR.Fine-needle aspiration biopsy of the thyroid:an appraisal[J].Ann Int Med,1993,118(4):282-289.
6.Amrikachi M,Ramzy I,Rubenfeld S,et al.Accuracy of fine-needle aspiration of thyroid[J].Arch Pathol Lab Med,2001,125(4):484-488.
7.Musgrave YM,Davey DD,Weeks JA,et al.Assessment of fine needle aspiration sampling techniques in thyroid nodules[J].Daign Cytopathol,1998,18(1):76-80.
8.Werga P,Wallin G,Skoog L,et al.Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management[J].World J Surg,2000,24(8):907-912.
9.Giard RW,Hermans J.Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma:an audit using a national pathology database[J].Cancer,2000,90(6):330-334.
10.Yang J,Schnadig V,Logrono R,et al.Fine-needle aspiration of thyroid nodules:a study of 4703 patients with histologic and clinical correlations[J].Cancer,2007,111(5):306-315.
11.任玉波,马青松,梁风泉.细针吸取细胞学诊断甲状腺结节的探讨[J].中国肿瘤临床,2003,30(2):112-115.
12.Hawkins F,Bellido D,Bernal C,et al.Fine needle aspiration biopsy in the diagnosis of thyroid cancer and thyroid disease[J].Cancer,1987,59(6):1206-1209.
13.Burch HB,Burman KD,Reed LH,et al.Fine needle aspiration of thyroid nodules.Determinants of insufficiency rate and malignancy yield at thyroidectomy[J].Acta Cytol,1996,40(6):1176-1183.
14.Ravetto C,Colombo L,Dottorini ME.Usefulness of fine needle aspiration in the diagnosis of thyroid carcinoma:a retrospective study in 37,895 patients[J].Cancer,2000,90(6):357-363.
15.Mehrotra P,Viswanathan H,Johnson SJ,et al.Ultrasound guidance improves the adequacy of our preoperative thyroid cytology but not its accuracy[J].Cytopathology,2006,17(4):137-144.
16.Braga M,Cavalcanti TC,Collaco LM,et al.Efficacy of ultrasound- guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules[J].J Clin Endocrinol Metab,2001,86(9):4089-4091.
17.刘春波,高晓虹,王俊峰等.超声引导及触诊下细针穿刺活检对甲状腺结节的诊断对比观察[J].中国超声诊断杂志,2004,5(4):249-251.
18.Papini E,Guglielmi R,Bianchini A,et al.Risk of malignancy in nonpalpable thyroid nodules:predictive value of ultrasound and color-Doppler features[J].J Clin Endocrinol Metab,2002,87(5):1941-1946.
19.Sangalli G,Serio G,Zampatti C,et al.Fine needle aspiration cytology of the thyroid:a comparison of 5469 cytological and final histological diagnoses[J].Cytopathology,2006,17(5):245-250.
20.Cappelli C,Castellano M,Pirola I,et al.The predictive value of ultrasound findings in the management of thyroid nodules[J].QJM,2007,100(1):29-35.
21.Screaton NJ,Berman LH,Grant JW.US-guided core-needle biopsy of the thyroid gland[J].Radiology,2003,226(3):827-832.
22.Harvey JN,Parker D,De P,et al.Sonographically guided core biopsy in the assessment of thyroid nodules[J].J Clin Ultrasound,2005,33(2):57-62.
23.Taki S,Kakuda K,Kakuma K,et al.Thyroid nodules:evaluation with US-guided core biopsy with an automated biopsy gun[J].Radiology,1997,202(3):874-877.
24.Quinn SF,Nelson HA,Demlow TA.Thyroid biopsies:fine-needle aspiration biopsy versus spring-activated core biopsy needle in 102 patients[J].J Vasc Interv Radiol,1994,5(4):619-623.
25.Baloch ZW,Gupta PK,Yu GH,Sack MJ,et al.Follicular variant of papillary carcinoma.Cytologic and histologic correlation[J].Am J Clin Pathol,1999,111(2):216-222.
26.Kaneko C,Shamoto M,Niimi H,et al.Studies on intranuclear inclusions and nuclear grooves in papillary thyroid cancer by light,scanning electron and transmission electron microscopy[J].Acta Cytol,1996,40(3):417-422.
27.Das A,Gupta SK,Srinivasan R,et al.Atypical cytologic features of medullary carcinoma of the thyroid[J].Acta Cytol,1992,36:137-140.
28.Doria R,Jekel JF,Cooper DL.Thyroid lymphoma.The case for combined modality therapy[J].Cancer,1994,73(1):200-206.
29.Tsang RW,Gospodarowicz MK,Sutcliffe SB,et al.Non-Hodgkin's lymphoma of the thyroid gland:prognostic factors and treatment outcome.The Princess Margaret Hospital Lymphoma Group[J].Int J Radiat Oncol Biol Phys,1993,27(3):599-604.
30.Ohye H,Fukata S,Hirokawa M.Malignant lymphoma of the thyroid[J].Nippon Rinsho,2007,65(11):2092-2098.
31.Yang H,Li J,Shen T.Primary T-cell lymphoma of the thyroid:case report and review of the literature[J].Med Oncol,2008,25(4):462-466.
32.Pedersen RK,Pedersen NT.Primary non-Hodgkin's lymphoma of the thyroid gland:a population based study[J].Histopathology,1996,28(1):25-32.
33.Derringer GA,Thompson LD,Frommelt RA,et al.Malignant lymphoma of the thyroid gland:a clinicopathologic study of 108 cases[J].Am J Surg Pathol,2000,24(5):623-639.
34.周庚寅,觉道健一.甲状腺病理与临床[M].北京:人民卫生出版社2005:193-194.
35.Pasieka JL.Hashimoto's disease and thyroid lymphoma:role of the surgeon[J].World J Surg,2000,24(8):966-970.
36.Cha C,Chen H,Westra WH,et al.Primary Thyroid Lymphoma:Can the Diagnosis Be Made Solely by Fine-Needle Aspiration[J]? Ann Surg Oncol,2002,9(3):298-302.
37.Quinn SF,Sheley RC,Nelson HA,et al.The role of percutaneous needle biopsies in the original diagnosis of lymphoma:a prospective evaluation[J].J Vasc Interv Radiol,1995,6(6):947-952.
38.Riazmontazer N,Bedayat G.Psammoma bodies in fine needle aspirates from thyroids containing nontoxic hyperplastic nodular goiters[J].Acta Cytol,1991,35(5):563-566.
39.Baloch ZW,Fleisher S,LiVolsi VA,et al.Diagnosis of "follicular neoplasm":a gray zone in thyroid fine-needle aspiration cytology[J].Diagn Cytopathol,2002,26(1):41-44.
40.周庚寅,觉道健一.甲状腺病理与临床[M].北京:人民卫生出版社,2005:240-241.
41.Kim DW,Lee EJ,Kim SH,et al.Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules:comparison in efficacy according to nodule size[J].Thyroid,2009,19(1):27-31.
42.Frates MC,Benson CB,Doubilet PM,et al.Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography[J].J Clin Endocrinol Metab,2006,91(9):3411-3417.
43.Yuan WH,Chiou HJ,Chou YH,et al.Gray-scale and color Doppler ultrasonographic manifestations of papillary thyroid carcinoma:analysis of 51cases[J].Clin Imaging,2006,30(6):394-401.
44.Choi KU,Kim JY,Park DY,et al.Recommendations for the management of cystic thyroid nodules[J].ANZ J Surg,2005,75(7):537-541.
45.Lee MJ,Kim EK,Kwak JY,et al.Partially cystic thyroid nodules on ultrasound:probability of malignancy and sonographic differentiation[J].Thyroid,2009,19(4):341-346.
46.Lin JD,Hsuen C,et al.Cystic change in thyroid cancer[J].ANZ J Surg,2007,77(6):450-454.
47.Lee KR,Ashfaq R,Birdsong GG,et al.Comparison of conventional Papanicolaou smears and a fluid-based,thin-layer system for cervical cancer screening[J].Obstet Gynecol,1997,90(2):278-284.
48.Nassar H,Ali-Fehmi R,Madan S.Use of ThinPrep monolayer technique and cytospin preparation in urine cytology:a comparative analysis[J].Diagn Cytopathol,2003,28(3):115-118.
49.Parfitt JR,McLachlin CM,Weir MM.Comparison of ThinPrep and conventional smears in salivary gland fine-needle aspiration biopsies[J].Cancer,2007,111(2):123-129.
50. Veneti S, Daskalopoulou D, Zervoudis S,et al.Liquid-based cytology in breast fine needle aspiration. Comparison with the conventional smear[J]. Acta Cytol,2003, 47(2):188-192.
51. Michael CW, Pang Y, Pu RT, Hasteh F, Griffith KA. Cellular adequacy for thyroid aspirates prepared by ThinPrep: how many cells are needed[J]?Diagn Cytopathol,2007,35(12):792-797.
52. Fadda G, Rossi ED, Raffaelli M, Fine-needle aspiration biopsy of thyroid lesions processed by thin-layer cytology: one-year institutional experience with histologic correlation[J].Thyroid, 2006,16(10):975- 981.
53. Witt RL.A comparison of the results of monolayer versus smear cytopreparatory techniques for fine-needle aspiration in 100 consecutive patients undergoing thyroidectomy: a surgeon's perspective [J].Otolaryngol Head Neck Surg,2004, 131(6):964-967.
54. Frost AR, Sidawy MK, Ferfelli M, Utility of thin-layer preparations in thyroid fine-needle aspiration: diagnostic accuracy, cytomorphology, and optimal sample preparation[J]. Cancer, 1998,84(1): 17-25.
55. Nguyen GK, Ginsberg J, Crockford PM. Fine-needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules [J].Pathol Annu,1991,25(1):63- 91.
56. Hor T, Lahiri SW. Bilateral Thyroid Hematomas after Fine-Needle Aspiration Causing Acute Airway Obstruction [J].Thyroid,2008,18(5):567-569.
1.Wild JJ,Reid JM.Application of echo-ranging techniques to the determination of the structure of biological tissues[J].Science,1952,115(2983):226-230.
2.Cardinal HN,Gill JD,Fenster A.Analysis of geometrical distortion and statistical variance in length,area,and volume in a linearly scanned 3-D ultrasound image[J].IEEE Trans Med Imaging,2000,19(6):632-651.
3.Smith SW,Trahey GE,von Ramm OT.Two-dimensional arrays for medical ultrasound[J].Ultrason Imaging,1992,14(3):213-233.
4.焦明德,蔡爱露,吴长君,等主编.实用三维超声诊断学[M].北京:军事医学出版社,2003,9-13.
5.Robb RA.Three-dimensional Biomedical Imaging:Principles and Practice [M].1995(New York:VCH)
6.Gerscovich EO,Greenspan A,Cronan MS,et al.Three-dimensional sonographic evaluation of developmental dysplasia of the hip:preliminary findings[J].Radiology,1994,190(2):407-410.
7.Blake CC,Elliot TL,Slomka PJ,et al.Variability and accuracy of measurements of prostate brachytherapy seed position in vitro using three-dimensional ultrasound:an intra- and inter-observer study[J].Med Phys,2000,27(12):2788- 2795.
8.Guo Z,Fenster A.Three-dimensional power Doppler imaging:a phantom study to quantify vessel stenosis[J].Ultrasound Med Biol,1996,22(8):1059-1069.
9.杨秀贞.代丽娜.彩色多普勒血流图及能量图对甲状腺良恶性肿瘤诊断价值[J].黑龙江医学,2006,30(9):719-720.
10.Alcazar JL,Galvan R.Three-dimensional power Doppler ultrasound scanning for the prediction of endometrial cancer in women with postmenopausal bleeding and thickened endometrium[J].Am J Obstet Gynecol,2009,200(1):44.el-6.
11.Pretorius DH,Nelson TR,Baergen RN,Imaging of placental vasculature using three-dimensional ultrasound and color power Doppler:a preliminary study[J].Ultrasound Obstet Gynecol,1998,12(1):45-49.
12.Correale M,Ieva R,Di Biase M.Real-time three-dimensional echocardiography:an update[J].Eur J Intern Med,2008,19(4):241-248.
13.Hotta N,Ayada M,Okumura A,et al.Usefulness of live 3D echocardiography during radiofrequency ablation in a case of hepatocellular carcinoma[J]. Clin Imaging, 2007, 31(4):283-286.
14. Xu HX, Yin XY, Lu MD, et al. Usefulness of three-dimensional sonography in procedures of ablation for liver cancers: initial experience[J]. J Ultrasound Med,2003,22(11):1239-1247.
15. Mehta SS, Azzouzi AR, Hamdy FC.Three dimensional ultrasound and prostate cancer[J].World J Urol,2004,22(5):339-345.
16. Surry KJ, Smith WL, Campbell LJ,The development and evaluation of a three-dimensional ultrasound-guided breast biopsy apparatus[J]. Med Image Anal,2002, 6(3):301-312.
17. Rotten D, Levaillant JM, Zerat L. Analysis of normal breast tissue and of solid breast masses using three-dimensional ultrasound mammography[J]. Ultrasound Obstet Gynecol, 1999,14(2): 114-124.
18. Huang SF, Chang RF, Moon WK, et al. Analysis of tumor vascularity using three-dimensional power Doppler ultrasound images[J]. IEEE Trans Med Imaging,2008,27(3):320-330.
19. Chang RF, Huang SF, Moon WK, et al. Solid breast masses: neural network analysis of vascular features at three-dimensional power Doppler US for benign or malignant classification [J].Radiology,2007,243(1): 56-62.
20. Hsiao YH, Huang YL, Liang WM, et al. Characterization of benign and malignant solid breast masses: harmonic versus nonharmonic 3D power Doppler imaging[J]. Ultrasound Med Biol,2009,35(3):353-359.
21. Lyshchik A, Drozd V, Schloegl S, et al. Three-dimensional ultrasonography for volume measurement of thyroid nodules in children[J]. J Ultrasound Med, 2004,23(2):247-254.
22. Lyshchik A, Drozd V, Reiners C. Accuracy of three-dimensional ultrasound for thyroid volume measurement in children and adolescents.Thyroid,2004,14 (2):113-120.
23. Sonographic measurement of thyroid gland volume: A comparison of 2D and 3D ultrasound[J].Radiology,2005,11(4):242-248.
24. Andermann P, Schlogl S, Mader U, et al.Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound[J]. Nuklearmedizin,2007,46(1): 1 -7.
25. Ng E, Chen T, Lam R,Three-dimensional ultrasound measurement of thyroid volume in asymptomatic male Chinese[J]. Ultrasound Med Biol, 2004,30(11): 1427-1433.
26.Slapa RZ,Slowinska-Srzednicka J,Szopinski KT,et al.Gray-scale three-dimensional sonography of thyroid nodules:feasibility of the method and preliminary studies[J].Eur Radiol,2006,16(2):428-436.
27.李建国,强沁晨,刘月洁,等.甲状腺血管能量三维超声技术相关技巧探讨[J].中国医学影像技术,2001,17(2):139-140.
28.王淑玲,蒋雪梅,刘鸿玉.彩色多普勒和三维能量成像在甲状腺弥漫性病变中的应用[J].临床超声医学杂志,2001,3(1):19-21.
29.张超学,张新书,王玲,等.甲状腺腺瘤血管结构的三维重建及血管容积指数特点分析[J].中国超声医学杂志,2005,21(3):220-223.
30.江泉,柏宁野,赵玉华,等.三维血管能量图超声在甲状腺结节诊断中的应用[J].中国超声医学杂志,2008,24(7):598-600.
31.李锐,郭燕丽,华兴,等.彩色多普勒血流图与三维彩色能量图在诊断甲状腺局限性病变中的应用价值[J].第三军医大学学报,2005,27(12):1282-1284.
32.孙霞,刘书海,张清泉,等.甲状腺肿瘤三维血管定量与病理微血管定量相关性研究[J].中国超声医学杂志,2004,20(12):891-893.
1.Singer PA,Cooper DS,Daniels GH,et al.Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer[J].American Thyroid Association.Arch Intern Med,1996,156(19):2165-2172.
2.Wong CK,Wheeler MH.Thyroid nodules:rational management[J].World J Surg,2000,24(8):934-941.
3.Gharib H,Papini E,Paschke R.Thyroid nodules:a review of current guidelines,practices,and prospects[J].Eur J Endocrinol,2008,159(5):493-505.
4.Ljung BM,Langer J,Mazzaferri EL,et al.Training,credentialing and re-credentialing for the performance of a thyroid FNA:a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference[J].Diagn Cytopathol,2008,36(6):400-406.
5.Marqusee E,Benson CB,Frates MC,et al.Usefulness of ultrasonography in the management of nodular thyroid disease[J].Ann Intern Med,2000,133(9):696-700.
6.Mehrotra P,Viswanathan H,Johnson SJ,et al.Ultrasound guidance improves the adequacy of our preoperative thyroid cytology but not its accuracy[J].Cytopathology,2006,17(4):137-144.
7.Braga M,Cavalcanti TC,Collaco LM,et al.Efficacy of ultrasound-guided fine-needle aspiration bigpsy in the diagnosis of complex thyroid nodules[J].J Clin Endocrinol Metab,2001,86(9):4089-4091.
8.刘春波,高晓虹,王俊峰等.超声引导及触诊下细针穿刺活检对甲状腺结节的诊断对比观察[J].中国超声诊断杂志,2004,5(4):249-251.
9.Cesur M,Corapcioglu D,Bulut S,et al.Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules[J].Thyroid,2006,16(6):555-561.
10.Kollur SM,El Sayed S,El Hag IA.Follicular thyroid lesions coexisting with Hashimoto's thyroiditis:incidence and possible sources of diagnostic errors[J].Diagn Cytopathol,2003,28(1):35 -38.
11.Nguyen GK,Ginsberg J,Crockford PM,et al.Hashimoto's thyroiditis:cytodiagnostic accuracy and pitfalls[J].Diagn Cytopathol,1997,16(6):531-536.
12.Granter SR,Cibas ES.Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism[J]. Am J Clin Pathol, 1997,107(1):20-25.
13. Orell SR, Philips J. Broadsheet number 57: problems in fine needle biopsy of the thyroid[J]. Pathology, 2000, 32(3): 191-198.
14. Papanicolaou Society of Cytopathology Task Force on Standard of Practice (Suen KC, Chair): Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules[J]. Diagn Cytopathol, 1996, 15(1): 84-89.
15. Zhu W, Michael CW. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases[J]. Diagn Cytopathol, 2007,35(3): 183-186.
16. Redman R, Zalaznick H, Mazzaferri EL,et al. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules[J]. Thyroid, 2006,16(1):55-60.
17. Hegedus L. Clinical practice. The thyroid nodule[J]. N Engl J Med,2004,351(17): 1764-1771.
18. Kelly NP, Lim JC, DeJong S, et al. Specimen adequacy and diagnostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules[J].Diagn Cytopathol, 2006,34(3):188-191.
19. Layfield LJ, Wax T, Jones C Cytologic distinction of goiterous nodules from morphologically normal thyroid: analyses of cytomorphologic features[J]. Cancer, 2003,99(4):217-222.
20. Anderson SR, Mandel S, LiVolsi VA, et al. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease[J]? Diagn Cytopathol, 2004,31(1):64-67.
21. Kim WB, Han SM, Kim TY, et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease[J]. Clin Endocrinol,2004,60(6):719-725.
22. Kumar N, Ray C, Jain S. Aspiration cytology of Hashimoto's thyroiditis in an endemic area[J]. Cytopathology, 2002,13(1):31-39.
23. MacDonald L, Yazdi HM. Fine needle aspiration biopsy of Hashimoto's thyroiditis[J]. Sources of diagnostic error. Acta Cytol, 1999,43(3):400-406.
24. Baloch ZW, Fleisher S, LiVolsi VA, Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology[J]. Diagn Cytopathol, 2002,26(1):41-44.
25. Pu RT, Yang J, Wasserman PG, et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration[J]? Diagn Cytopathol, 2006,34(5):330-334.
26. Clary KM, Condel JL, Liu Y, et al. Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland[J].Acta Cytol, 2005,49(4):378-382.
27. Elliott DD, Pitman MB, Bloom L.et al. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis[J]. Cancer, 2006 25,108(2):102-109.
28. Das DK, Mallik MK, Sharma P, et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant[J]. Acta Cytol, 2004,48(3):325-336.
29. Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens[J]. Am J Clin Pathol, 2006,125(Suppl):S135-144
30. Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma[J]. Endocr Pathol, 2006,17(1):1-18.
31. Zacks JF, de las Morenas A, Beazley RM Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid[J]. Diagn Cytopathol, 1998,18(2):87-90.
32. Solomon A, Gupta PK, LiVolsi VA, et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens[J]. Diagn Cytopathol, 2002,27(3): 143-148.
33. Collins BT, Cramer HM, Tabatowski K, Fine needle aspiration of medullary carcinoma of the thyroid. Cytomorphology, immunocytochemistry and electron microscopy[J]. Acta Cytol, 1995,39(5):920-930.
34. Cha C, Chen H, Westra WH, Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration[J]? Ann Surg Oncol, 2002,9(3):298-302.
35. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal[J]. Ann Intern Med, 1993,118(4):282-289.
36. Nguyen GK, Ginsberg J, Crockford PM. Fine-needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules [J]. Pathol Annu, 1991, 25(1):63-91.
37. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2006,16(2):109-142.
38. Marqusee E, Benson CB, Frates MC, et al Usefulness of ultrasonography in the management of nodular thyroid disease[J]. Ann Intern Med, 2000,133(9):696-700.
39. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features[J]. J Clin Endocrinol Metab, 2002 ,87(5): 1941-1946.
40. Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy[J]. J Ultrasound Med, 2003,22(10): 1027-1031.
41. Ylagan LR, Farkas T, Dehner LP. Fine needle aspiration of the thyroid: a cytohistologic correlation and study of discrepant cases[J]. Thyroid, 2004,14(1): 35-41.
42. Orlandi A, Puscar A, Capriata E, et al. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up[J]. Thyroid, 2005,15(3):274-278.
43. Wemeau JL, Caron P, Schvartz C, Schlienger JL, et al.Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group[J]. J Clin Endocrinol Metab, 2002,87(11):4928-3494.
44. Yang J, Schnadig V, Logrono R, Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations[J].Cancer,2007,111(5):306-315.
45. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid[J]. AJR Am J Roentgenol, 2002,178(3):687-691.
46. Baloch ZW, LiVolsi VA, Asa SL, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference[J]. Diagn Cytopathol, 2008,36(6):425-437.
47. Gharib H, Papini E, Valcavi R, et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J].Endocr Pract,2006,12(1):63-102.
48. Malle D, Valeri RM, Pazaitou-Panajiotou K, et al. Use of a thin-layer technique in thyroid fine needle aspiration[J]. Acta Cytol, 2006,50(1):23-27.
49. Saggiorato E, De Pompa R, Volante M, et al. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application[J]. Endocr Relat Cancer, 2005,12(2):305-317.
50. Baloch ZW, Sack MJ, Yu GH, et al. Fine-needle aspiration of thyroid: an institutional experience[J]. Thyroid, 1998,8(7):565-569.
51. Katoh R, Miyagi E, Nakamura N, Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas[J]. Hum Pathol, 2000,31(3):386-393.
52. Nikiforova MN, Biddinger PW, Caudill CM, et al. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses[J]. Am J Surg Pathol, 2002,26(8): 1016-1623.
53. Cheung CC, Carydis B, Ezzat S, et al. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer[J]. J Clin Endocrinol Metab. 2001,86(5):2187-2190.
54. Papotti M, Volante M, Saggiorato E,et al. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma[J]. Eur J Endocrinol, 2002,147(4):515-521.
55. Saggiorato E, Cappia S, De Giuli P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma[J]. J Clin Endocrinol Metab, 2001,86(11):5152-5158.
56. Takano T, Miyauchi A, Matsuzuka F, et al. Diagnosis of thyroid malignant lymphoma by reverse transcription-polymerase chain reaction detecting the monoclonality of immunoglobulin heavy chain messenger ribonucleic acid[J]. J Clin Endocrinol Metab, 2000,85(2):671-675.